You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
DROSPIRENONE/ETHINYLOESTRADIOL-ALPHAPHARM 3/20 is indicated for use as:
an oral contraceptive.
treatment of moderate acne vulgaris in women who seek oral contraception
treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who have chosen oral contraceptives as their method of birth control. The efficacy of drospirenone 3 mg/ethinyloestradiol 20 µg tablets for PMDD was not assessed beyond 3 cycles. Drospirenone 3 mg/ethinyloestradiol 20 µg tablets has not been evaluated for treatment of PMS (premenstrual syndrome) (see CLINICAL TRIALS).
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
DROSPIRENONE/ETHINYLOESTRADIOL-ALPHAPHARM 3/20 is indicated for use as:
an oral contraceptive.
treatment of moderate acne vulgaris in women who seek oral contraception
treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who have chosen oral contraceptives as their method of birth control. The efficacy of drospirenone 3 mg/ethinyloestradiol 20 µg tablets for PMDD was not assessed beyond 3 cycles. Drospirenone 3 mg/ethinyloestradiol 20 µg tablets has not been evaluated for treatment of PMS (premenstrual syndrome) (see CLINICAL TRIALS).
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
DROSPIRENONE/ETHINYLOESTRADIOL-ALPHAPHARM 3/20 is indicated for use as:
an oral contraceptive.
treatment of moderate acne vulgaris in women who seek oral contraception
treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who have chosen oral contraceptives as their method of birth control. The efficacy of drospirenone 3 mg/ethinyloestradiol 20 µg tablets for PMDD was not assessed beyond 3 cycles. Drospirenone 3 mg/ethinyloestradiol 20 µg tablets has not been evaluated for treatment of PMS (premenstrual syndrome) (see CLINICAL TRIALS).
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
DROSPIRENONE/ETHINYLOESTRADIOL-ALPHAPHARM 3/20 is indicated for use as:
an oral contraceptive.
treatment of moderate acne vulgaris in women who seek oral contraception
treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who have chosen oral contraceptives as their method of birth control. The efficacy of drospirenone 3 mg/ethinyloestradiol 20 µg tablets for PMDD was not assessed beyond 3 cycles. Drospirenone 3 mg/ethinyloestradiol 20 µg tablets has not been evaluated for treatment of PMS (premenstrual syndrome) (see CLINICAL TRIALS).
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
DROSPIRENONE/ETHINYLOESTRADIOL-ALPHAPHARM 3/20 is indicated for use as:
an oral contraceptive.
treatment of moderate acne vulgaris in women who seek oral contraception
treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who have chosen oral contraceptives as their method of birth control. The efficacy of drospirenone 3 mg/ethinyloestradiol 20 µg tablets for PMDD was not assessed beyond 3 cycles. Drospirenone 3 mg/ethinyloestradiol 20 µg tablets has not been evaluated for treatment of PMS (premenstrual syndrome) (see CLINICAL TRIALS).
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
DROSPIRENONE/ETHINYLOESTRADIOL-ALPHAPHARM 3/20 is indicated for use as:
an oral contraceptive.
treatment of moderate acne vulgaris in women who seek oral contraception
treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who have chosen oral contraceptives as their method of birth control. The efficacy of drospirenone 3 mg/ethinyloestradiol 20 µg tablets for PMDD was not assessed beyond 3 cycles. Drospirenone 3 mg/ethinyloestradiol 20 µg tablets has not been evaluated for treatment of PMS (premenstrual syndrome) (see CLINICAL TRIALS).
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
DROSPIRENONE/ETHINYLOESTRADIOL-ALPHAPHARM 3/20 is indicated for use as:
an oral contraceptive.
treatment of moderate acne vulgaris in women who seek oral contraception
treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who have chosen oral contraceptives as their method of birth control. The efficacy of drospirenone 3 mg/ethinyloestradiol 20 µg tablets for PMDD was not assessed beyond 3 cycles. Drospirenone 3 mg/ethinyloestradiol 20 µg tablets has not been evaluated for treatment of PMS (premenstrual syndrome) (see CLINICAL TRIALS).
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
DROSPIRENONE/ETHINYLOESTRADIOL-ALPHAPHARM 3/20 is indicated for use as:
an oral contraceptive.
treatment of moderate acne vulgaris in women who seek oral contraception
treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who have chosen oral contraceptives as their method of birth control. The efficacy of drospirenone 3 mg/ethinyloestradiol 20 µg tablets for PMDD was not assessed beyond 3 cycles. Drospirenone 3 mg/ethinyloestradiol 20 µg tablets has not been evaluated for treatment of PMS (premenstrual syndrome) (see CLINICAL TRIALS).
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
DROSPIRENONE/ETHINYLOESTRADIOL-ALPHAPHARM 3/20 is indicated for use as:
an oral contraceptive.
treatment of moderate acne vulgaris in women who seek oral contraception
treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who have chosen oral contraceptives as their method of birth control. The efficacy of drospirenone 3 mg/ethinyloestradiol 20 µg tablets for PMDD was not assessed beyond 3 cycles. Drospirenone 3 mg/ethinyloestradiol 20 µg tablets has not been evaluated for treatment of PMS (premenstrual syndrome) (see CLINICAL TRIALS).
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
DROSPIRENONE/ETHINYLOESTRADIOL-ALPHAPHARM 3/20 is indicated for use as:
an oral contraceptive.
treatment of moderate acne vulgaris in women who seek oral contraception
treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who have chosen oral contraceptives as their method of birth control. The efficacy of drospirenone 3 mg/ethinyloestradiol 20 µg tablets for PMDD was not assessed beyond 3 cycles. Drospirenone 3 mg/ethinyloestradiol 20 µg tablets has not been evaluated for treatment of PMS (premenstrual syndrome) (see CLINICAL TRIALS).
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
